Fragmin (dalteparin sodium)​

Choose Fragmin

Fragmin is a low molecular heparin with a number of indications which include extended treatment of symptomatic venous thromboembolism (VTE) and prevention of its recurrence in patients with solid tumours.

There is a wealth of experience with Fragmin and a broad range of indications for your patients

Established clinical experience:

• ​​​​​​​To date more than 85 million Fragmin syringes, vials and ampoules have been used in the UK¹

Broad range of clinical indications^2–7

• Extended treatment of symptomatic venous thromboembolism  (VTE) and prevention of its recurrence in patients with solid tumours
• Peri- and post-operative surgical thromboprophylaxis
• Thromboprophylaxis in patients bedridden due to a medical condition*
• Treatment of VTE
• Unstable angina and non-Q wave MI, administered concurrently with aspirin
• Prevention of clotting in the extracorporeal circulation during haemodialysis or haemofiltration^†
  

*Including, but not limited to: congestive cardiac failure (NYHA class III or IV), acute respiratory failure or acute infection, who also have a predisposing risk factor for VTE such as age over 75 years, obesity, cancer or previous history of VTE.~

^†In patients with chronic renal insufficiency or acute renal failure.

Simple dosing regimen:

Once or twice daily dosing using colour-coded syringes and other presentations^2-7